Baxter receives preparedness contract from Austrian Ministry of Health for Pandemic Influenza Vaccine
» read more
Baxter Announces Safety and Immunogenicity Results from Phase I/II Clinical Trial of Cell-Based Candidate H5N1 Pandemic Vaccine
» read more
Baxter initiates clinical study with cell-based candidate H5N1 Pandemic Vaccine
» read more
|